Despite estimates that, each year, as many as 300 million dengue virus (DENV) infections
result in either no perceptible symptoms (asymptomatic) or symptoms that are sufficiently mild …

Background The transmissibility of SARS-CoV-2 determines both the ability of the virus to
invade a population and the strength of intervention that would be required to contain or …

Background Madagascar accounts for 75% of global plague cases reported to WHO, with
an annual incidence of 200–700 suspected cases (mainly bubonic plague). In 2017, a …

The Global Program to Eliminate Lymphatic Filariasis (LF) has a target date of 2020. This
program is progressing well in many countries. However, progress has been slow in some …

Since its introduction in December of 2019, SARS-CoV-2, the virus that causes COVID-19
disease, has rapidly spread across the world. Whilst vaccines are being rolled out, non-…

Individual-based models provide modularity and structural flexibility necessary for modeling
of infectious diseases at the within-host and population levels, but are challenging to …

Mathematical models within the Ross–Macdonald framework increasingly play a role in our
understanding of vector-borne disease dynamics and as tools for assessing scenarios to …

Statins are widely used as medication to lower cholesterol levels in human patients. In addition,
it was recently reported that they also reduce the incidence of stroke and progression of …

During the past 100 years, Rift Valley fever virus (RVFV), a mosquito-borne virus, has caused
potentially lethal disease in livestock, and has been associated with significant economic …

Introduction In 2020, the first Dutch West Nile virus (WNV) infected birds were detected through
risk-targeted surveillance of songbirds. Retrospective testing of patients with unexplained …